Comparative evaluation of effectiveness of diclofenac sodium gel (3%) phonophoresis and piroxicam gel (0.5%) phonophoresis in management of temporomandibular disorders – a single blind, randomized controlled trial.

Comparative evaluation of effectiveness of diclofenac sodium gel (3%) phonophoresis and piroxicam gel (0.5%) phonophoresis in management of temporomandibular disorders – a single blind, randomized controlled trial. - TMDS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062681

Enrollment

Registered

2024-02-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Non-steroidal anti-inflammatory drugs: diclofenac sodium gel (3%) phonophoresis,3gm per day, once a day for 5 consecutive days. Control Intervention1: Non-steroidal anti-inflammatory d

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling the Diagnostic criteria for temporomandibular disorders (DC/TMD) for Pain-Related temporomandibular disorders which include Myalgia (Local myalgia, myofascial pain, and myofascial pain with referral} and Arthralgia. 2.Recurrent and chronic history of pain 3.Pharmacologic washout of =72 hours for central analgesic, NSAIDS, and antidepressants. 4.Patients who have given Informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients fulfilling the DC/TMD CRITERIA of Diagnostic Procedures for Pain Related temporomandibular disorder which include Headache attributed to TMD, Disc derangement , Degenerative joint disease, Subluxation. ? Patients on analgesics or anti-inflammatory medication who are not willing to discontinue 2.Patients on Physiotherapy /complementary and alternative medicine for the same problem. 3.Patient giving previous history of allergy to diclofenac sodium and piroxicam drugs. 4.Patients with cardiac pacemakers and implanted defibrillators 5.Patients with jaw Tumors , fractures 6.Systemically compromised patients 7.Pregnant females 8.Patient not willing to give informed consent.

Design outcomes

Primary

Measure	Time frame
Intensity of pain ,Pressure pain threshold ,Maximum interincisal openingTimepoint: Intensity of pain ,Pressure pain threshold ,Maximum interincisal opening	—

Secondary

Measure	Time frame
Quality of lifeTimepoint: Quality of life	—

Countries

India

Contacts

Public ContactDRSHRUTI SARYAM

GOVERMENT DENTAL COLLEGE AND HOSPITAL NAGPUR

kalaskarashita@gmail.com8208487687

Outcome results